These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14750637)

  • 21. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?
    Kim JH; Sung IK; Hong SN; Lee SY; Park HS; Shim CS
    Dig Dis Sci; 2013 Jun; 58(6):1663-7. PubMed ID: 23443492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.
    Johnsson F; Weywadt L; Solhaug JH; Hernqvist H; Bengtsson L
    Scand J Gastroenterol; 1998 Jan; 33(1):15-20. PubMed ID: 9489902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?
    Farup PG; Juul-Hansen PH; Rydning A
    J Clin Gastroenterol; 2001 Sep; 33(3):206-9. PubMed ID: 11500608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].
    Maev IV; Balashova NN; Busarova GA
    Klin Med (Mosk); 2003; 81(9):54-9. PubMed ID: 14598594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.
    Anandasabapathy S; Jaffin BW
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):563-70. PubMed ID: 16944654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease.
    Bate CM; Riley SA; Chapman RW; Durnin AT; Taylor MD
    Aliment Pharmacol Ther; 1999 Jan; 13(1):59-66. PubMed ID: 9892880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
    Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
    Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole.
    Nelson WW; Vermeulen LC; Geurkink EA; Ehlert DA; Reichelderfer M
    Arch Intern Med; 2000 Sep; 160(16):2491-6. PubMed ID: 10979061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.